- Home
- APLT vs SKIN Comparison
APLT vs SKIN Comparison
Compare APLT & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- SKIN
- Stock Information
- Founded
- APLT 2016
- SKIN 1997
- Country
- APLT United States
- SKIN United States
- Employees
- APLT N/A
- SKIN N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- SKIN Package Goods/Cosmetics
- Sector
- APLT Health Care
- SKIN Consumer Discretionary
- Exchange
- APLT Nasdaq
- SKIN Nasdaq
- Market Cap
- APLT 178.6M
- SKIN 176.3M
- IPO Year
- APLT 2019
- SKIN N/A
- Fundamental
- Price
- APLT $1.28
- SKIN $1.43
- Analyst Decision
- APLT Buy
- SKIN Buy
- Analyst Count
- APLT 5
- SKIN 3
- Target Price
- APLT $4.13
- SKIN $2.42
- AVG Volume (30 Days)
- APLT 5.5M
- SKIN 1.1M
- Earning Date
- APLT 11-10-2025
- SKIN 11-06-2025
- Dividend Yield
- APLT N/A
- SKIN N/A
- EPS Growth
- APLT N/A
- SKIN N/A
- EPS
- APLT N/A
- SKIN N/A
- Revenue
- APLT $121,000.00
- SKIN $310,064,000.00
- Revenue This Year
- APLT N/A
- SKIN N/A
- Revenue Next Year
- APLT $5,935.35
- SKIN $5.64
- P/E Ratio
- APLT N/A
- SKIN N/A
- Revenue Growth
- APLT N/A
- SKIN N/A
- 52 Week Low
- APLT $0.30
- SKIN $0.78
- 52 Week High
- APLT $10.62
- SKIN $2.69
- Technical
- Relative Strength Index (RSI)
- APLT 60.36
- SKIN 37.19
- Support Level
- APLT $1.16
- SKIN $1.28
- Resistance Level
- APLT $1.50
- SKIN $1.55
- Average True Range (ATR)
- APLT 0.14
- SKIN 0.11
- MACD
- APLT -0.02
- SKIN 0.02
- Stochastic Oscillator
- APLT 61.64
- SKIN 40.00
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.